Liraglutide in islet transplantation: From bench to bedside

Transplant International

Volumn 23, Issue 3, 2010, Pages 257-258

  Berney, Thierry ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; LIRAGLUTIDE; TRANSCRIPTION FACTOR PDX 1;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG HALF LIFE; ENGRAFTMENT; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LANGERHANS CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; GLUCAGON-LIKE PEPTIDE 1; GRAFT SURVIVAL; HUMANS; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE;

EID: 75149139443     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.01018.x     Document Type: Note

References (12)

1. Toso C, McCall M, Emamaullee J, et al. Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int 2009 23: 259.
2. Nauck MA. Unraveling the science of incretin biology. Am J Med 2009 122: S3.
3. Pratley RE. Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes. Medscape J Med 2008 10: 171.
4. Ricordi C, Inverardi L, Kenyon NS, et al. Requirements for success in clinical islet transplantation. Transplantation 2005 79: 1298.
5. Faradji RN, Tharavanij T, Messinger S, et al. Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation 2008 86: 1658.
6. Froud T, Faradji RN, Pileggi A, et al. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation 2008 86: 36.
7. Gangemi A, Salehi P, Hatipoglu B, et al. Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant 2008 8: 1250.
8. Ghofaili KA, Fung M, Ao Z, et al. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation 2007 83: 24.
9. Emamaullee JA, Merani S, Toso C, et al. Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide. Endocrinology 2009 150: 2145.
10. Merani S, Truong W, Emamaullee JA, et al. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. Endocrinology 2008 149: 4322.
11. Parnaud G, Bosco D, Berney T, et al. Proliferation of sorted human and rat beta cells. Diabetologia 2008 51: 91.
12. Ihm SH, Matsumoto I, Zhang HJ, Ansite JD, Hering BJ. Effect of short-term culture on functional and stress-related parameters in isolated human islets. Transpl Int 2009 22: 207.